Andrew McNicoll

Andrew McNicoll is Senior Vice-President, Global Quality and Compliance where he is responsible for the implementation of the company’s global quality systems and compliance strategy and operations.

Andrew brings more than 30 years of progressively senior experience in quality and compliance management roles in the pharmaceutical and biologics industry. Prior to Joining Apotex, Andrew was with Patheon Inc., part of Thermo Fisher Scientific, as VP of Quality Systems and Global Compliance. Most recently, he served as VP of Quality for Patheon’s Biologics Business Unit. Prior to Patheon, Andrew held quality roles at AstraZeneca and Hemosol.

Andrew holds a Bachelor’s degree in Laboratory Science from Ryerson.